NAPG expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.743600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.749600E-01
Normal-vs-Stage2
4.213000E-01
Normal-vs-Stage3
9.603600E-01
Normal-vs-Stage4
5.293600E-01
Stage1-vs-Stage2
4.576000E-01
Stage1-vs-Stage3
8.323000E-01
Stage1-vs-Stage4
6.393200E-01
Stage2-vs-Stage3
3.897400E-01
Stage2-vs-Stage4
9.993800E-01
Stage3-vs-Stage4
5.797200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.991400E-01
Normal-vs-AfricanAmerican
3.668800E-01
Normal-vs-Asian
3.305800E-01
Caucasian-vs-AfricanAmerican
7.828400E-01
Caucasian-vs-Asian
8.708600E-01
AfricanAmerican-vs-Asian
8.715400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.704000E-01
Normal-vs-Female
4.804600E-01
Male-vs-Female
6.526200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.372200E-01
Normal-vs-Age(41-60Yrs)
2.396400E-01
Normal-vs-Age(61-80Yrs)
5.850400E-01
Normal-vs-Age(81-100Yrs)
7.362200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.273400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.386800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.473600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.726100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.186610E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.185600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.470800E-01
Normal-vs-Daily Drinker
9.571800E-01
Normal-vs-Weekly Drinker
4.794000E-01
Normal-vs-Occasional Drinker
3.142600E-01
Normal-vs-Social Drinker
3.213400E-01
Non Drinker-vs-Daily Drinker
4.546400E-01
Non Drinker-vs-Weekly Drinker
3.972200E-01
Non Drinker-vs-Occasional Drinker
1.076950E-01
Non Drinker-vs-Social Drinker
2.815200E-01
Daily Drinker-vs-Weekly Drinker
2.162000E-01
Daily Drinker-vs-Occasional Drinker
4.230400E-02
Daily Drinker-vs-Social Drinker
1.354980E-01
Weekly Drinker-vs-Occasional Drinker
4.773200E-01
Weekly Drinker-vs-Social Drinker
9.364400E-01
Occasional Drinker-vs-Social Drinker
4.708800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.667700E-02
Normal-vs-Grade 2
1.375810E-02
Normal-vs-Grade 3
5.298100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.708600E-01
Grade 1-vs-Grade 3
1.265040E-01
Grade 1-vs-Grade 4
8.667700E-02
Grade 2-vs-Grade 3
7.402300E-02
Grade 2-vs-Grade 4
1.375810E-02
Grade 3-vs-Grade 4
5.298100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.517800E-01
Normal-vs-NonDiabetic
4.041000E-01
Diabetic-vs-NonDiabetic
2.565400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.615200E-01
Normal-vs-NoPancreatitis
5.332600E-01
Pancreatitis-vs-NoPancreatitis
4.081400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.213600E-01
Normal-vs-N1
4.306600E-01
N0-vs-N1
8.478600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.061000E-01
Normal-vs-TP53-NonMutant
4.952400E-01
TP53-Mutant-vs-TP53-NonMutant
1.685740E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
